Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

77.28
Delayed Data
As of Feb 24
 -0.17 / -0.22%
Today’s Change
66.93
Today|||52-Week Range
83.58
+6.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Operating ActivitiesNet Income / Starting Line2.0B1.8B2.0B921.9M
 
 
 
 
 
Depreciation1.3B1.5B1.5B985.2M
 
 
 
 
 
Total Other Cash Flow299.9M93.4M-119.7M-782.6M
 
 
 
 
 
Funds From Operations3.6B3.4B3.4B1.1B
 
 
 
 
 
Funds From/For Other Operating Expenses2.1B282.6M116.0M-2.4B
 
 
 
 
 
Net Cash Flow - Operating Activities1.5B3.1B3.3B3.5B
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-775.3M
 
 
Decrease In Investments0.000.0089.2M777.9M
 
 
 
Capital Expenditures-377.3M-452.2M-449.6M-579.0M
 
 
 
 
 
Fixed Asset Disposal518.5M97.9M343.9M-799.6M
 
 
 
 
 
Net Assets From Acquisitions -405.8M-18.5M-107.1M-232.1M
 
 
 
 
 
Other Investing - Uses-521.4M-484.4M482.5M-371.8M
 
 
 
 
 
Other Investing - Sources29.4M4.5M-33.9M845.2M
 
 
 
 
 
Net Cash Flow Investing-756.6M-852.6M-764.5M-1.1B
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings5.5B-1.5B109.1M-2.2B
 
 
 
 
 
Long Term Debt Reduction0.000.00------
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-180.3M-98.5M-412.8M-415.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-6.3B-101.7M-42.7M29.3M
 
 
 
 
 
Other Sources - Financing0.005.0M-5.0M220.5M
 
 
 
 
Other Uses - Financing28.4M-28.4M9.0M-3.0M
 
 
 
 
 
Net Cash Flow - Financing-1.0B-1.7B-360.4M-2.3B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash39.2M-45.2M962.9K-381.2M
 
 
 
 
 
 
Net Change In Cash-251.9M618.3M2.1B203.2M